Regarding to a new multicenter study led by a University of Maryland radiation oncologist.

Gemcitabine interferes with the growth of cancers cells and can be used to take care of cancer of the breasts, pancreas and lung. It belongs to several medicines called antimetabolites. Although the new mixture therapy increased survival for individuals with pancreatic head cancer, researchers did not see any advantage for patients with cancer in other areas of the gland. Eighty-five % of pancreatic cancers are located in the top of the pancreas. Medical procedures to remove this type of tumor, combined with the entire pancreas head, part of the little intestine and other nearby tissue, is named the Whipple procedure.Randomization occurred within 2 weeks after supplement K antagonists have been withdrawn. Outcome Measures All suspected research outcome events were assessed by a central, independent adjudication committee whose members were unaware of the combined group assignments and who reviewed the imaging results. The primary efficacy final result was symptomatic, verified recurrence of venous thromboembolism objectively, defined as the composite of deep-vein thrombosis or fatal or nonfatal pulmonary embolism.13,14 Pulmonary embolism was considered to be the cause of death if it was verified on autopsy or if loss of life was preceded by a diagnosis of either pulmonary embolism or deep-vein thrombosis and whenever the reason could not be related to an alternative diagnosis.15 Deaths were classified as being due to pulmonary embolism, bleeding, or other causes.